Viewing Study NCT07490002


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-03-31 @ 3:50 AM
Study NCT ID: NCT07490002
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-24
First Post: 2026-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC
Sponsor: Changhai Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module